My thoughts are that MYX is a good buy around the 30-40c range for those prepared to hold long term 3-5 years.
I'm of the belief there are no short term catalysts for change. Assumptions around FDA approvals are just that. There have been plenty of approval shifts and delays - looking at you tolsura and nuvaring. Short termers need not apply as there are other opportunities out there.
If MYX were doing vastly better than expected they would need to report. Otherwise the best we can hope for is that they show some stability improvement in August that validates investing at these low levels.
My thoughts are that MYX is a good buy around the 30-40c range...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M | |||
| Open | High | Low | Value | Volume |
| $5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 810 | $5.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.15 | 2033 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |